GDP in the US: FDA publishes YouTube Video on DSCSA Implementation
![GDP in Switzerland (GDP 3)](files/eca/userImages/training.img/Z-GDP3-GDP-in-Switzerland-neues-Layout.jpg)
Recommendation
12 September 2024
Basel, Switzerland
Specifics in the Distribution of Medicinal Products (Course in english language!)
The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research (CDER) has provided a webinar on the Drug Supply Chain Security Act (DSCSA) implementation.
According to the agency, during the webinar entitled "Implementing DSCSA: Stabilization Period and Expectations" the following topics are covered:
- "DSCSA implementation and expectations for trading partners to achieve interoperable, electronic tracing of products at the package level
- Recent guidance documents for industry related to supply chain security requirements
- The stabilization period from November 27, 2023, to November 27, 2024, which allows trading partners additional time to implement, troubleshoot, and mature their systems and processes while supporting the continued availability of products to patients"
The FDA writes that the intended audience includes trading partners (manufacturers, repackagers, wholesale distributors, dispenser) obligated to adhere to the DSCSA enhanced drug distribution security requirements, other stakeholders that may work with trading partners to develop systems and process for the DSCSA requirements and state regulators.
The video is available on the FDA website or can be viewed directly on YouTube.
Related GMP News
16.07.2024Templates for Shortage Prevention and Mitigation Plans issued by EMA
16.07.2024New Measures to Report Medicine Disappearances
16.07.2024GDP Non-Compliance Report for Czech Wholesale Distributor
16.07.2024Checklist for Implementation of GDP Principles - Part 9: Transportation
12.06.2024EU adopts Supply Chain Law - Implications for pharmaceutical Companies